Insight Molecular Diagnostics Inc.: shareholders and insiders

IMDXNASDAQHealthcare · In Vitro & In Vivo Diagnostic Substances

Price

$1.97

November 20, 2026Market cap $63M

What Ploutos Investor adds for Insight Molecular Diagnostics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Nov 20, 2026, from their own Form 4 filings.

8 Form 4s

Bought on the market

$12M

3 people

Sold on the market

–

nobody

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $12M by 3 people·no sales

  • 2025: no buys, no sales
  • 2026: bought $12M by 3 people, no sales
  • Nov 17, 2026Patrick W Smith
    Kind
  • Nov 17, 2026Broadwood Partners, L.p.
    Kind
  • Nov 17, 2026Broadwood Partners, L.p.
    Kind
  • Jul 1, 2026Lou SilvermanDirector
    Kind
  • Jul 1, 2026Andrew J. LastDirector
    Kind
  • Jul 1, 2026Andrew ArnoDirector
    Kind
  • Jun 11, 2026Lou SilvermanDirector
    Kind
  • Jun 11, 2026Andrew J. LastDirector
    Kind
  • Jun 11, 2026Andrew ArnoDirector
    Kind
  • Apr 27, 2026Broadwood Partners, L.p.
    Kind
  • Apr 27, 2026Broadwood Partners, L.p.
    Kind
  • Apr 24, 2026Broadwood Partners, L.p.
    Kind
  • Apr 24, 2026Broadwood Partners, L.p.
    Kind
  • Apr 23, 2026Broadwood Partners, L.p.
    Kind
  • Apr 23, 2026Broadwood Partners, L.p.
    Kind
  • Apr 20, 2026Broadwood Capital Inc
    Kind
  • Apr 20, 2026Broadwood Capital Inc
    Kind
  • Apr 17, 2026Broadwood Capital Inc
    Kind
  • Apr 17, 2026Broadwood Capital Inc
    Kind
  • Apr 16, 2026Broadwood Capital Inc
    Kind
  • Apr 16, 2026Broadwood Capital Inc
    Kind
  • Feb 10, 2026Neal C Bradsher
    Kind
  • Feb 10, 2026Neal C Bradsher
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 15, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by IMDX's officers and directors from 2018 up to November 21, 2025, 8 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%1 On a 13DApr 27, 2026 Latest filing
  • Broadwood Partners, L.P.with 2 more persons
    Share of class39.7%
  • Patrick W. Smithwith 1 more person
    Share of class10.5%
  • AWM Investment Company, Inc.
    Share of class10.0%
  • Bio-Rad LaboratoriesCommon Shares, No Par Value
    Share of class9.70%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • Broadwood Partners, L.P.39.7%From the filing of Apr 27, 2026

    The Reporting Persons are filing this Schedule 13D/A to report a change in their respective beneficial ownership percentages. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may take such actions with respect to their investment in the Issuer as they deem appropriate. In that regard, the Reporting Persons have been and may continue to be in contact with members of the Issuer's management, board of directors (the "Board…

    From the filing of Apr 27, 2026

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter
  • Millennium Mgmt (Englander)
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.95% of its shares outstanding were held short, -2.4% since the report before.

Shares held short
949.5K
2.95%
Since the report before973.0K on Sep 30, 2026
-2.4%
3.3
292.4K
More days to cover thanof 4,578 US-listed companies with enough volume
38%
Report date
Oct 15, 2026
  • Jun 30, 2025: Shares held short 305.9K
  • Jul 15, 2025: Shares held short 277.9K
  • Jul 31, 2025: Shares held short 277.3K
  • Aug 15, 2025: Shares held short 269.1K
  • Aug 29, 2025: Shares held short 251.0K
  • Sep 15, 2025: Shares held short 253.1K
  • Sep 30, 2025: Shares held short 278.9K
  • Oct 15, 2025: Shares held short 273.1K
  • Oct 31, 2025: Shares held short 165.6K
  • Nov 14, 2025: Shares held short 96.8K
  • Nov 28, 2025: Shares held short 119.3K
  • Dec 15, 2025: Shares held short 146.3K
  • Dec 31, 2025: Shares held short 163.2K
  • Jan 15, 2026: Shares held short 203.8K
  • Jan 30, 2026: Shares held short 225.1K
  • Feb 13, 2026: Shares held short 228.1K
  • Feb 27, 2026: Shares held short 194.8K
  • Mar 13, 2026: Shares held short 184.7K
  • Mar 31, 2026: Shares held short 368.3K
  • Apr 15, 2026: Shares held short 455.9K
  • Apr 30, 2026: Shares held short 713.2K
  • May 15, 2026: Shares held short 1.18M
  • May 29, 2026: Shares held short 1.28M
  • Jun 15, 2026: Shares held short 1.15M
  • Jun 30, 2026: Shares held short 1.01M
  • Jul 15, 2026: Shares held short 1.25M
  • Jul 31, 2026: Shares held short 1.07M
  • Aug 14, 2026: Shares held short 1.09M
  • Aug 31, 2026: Shares held short 930.7K
  • Sep 15, 2026: Shares held short 992.5K
  • Sep 30, 2026: Shares held short 973.0K
  • Oct 15, 2026: Shares held short 949.5K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading39.3% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 39.3% of the shares in the reported trades were short sales, against 54.9% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
39.3%
The 14 beforeOct 14, 2026 – Nov 2, 2026
54.9%
Change
-15.6 pts
Short sales a dayon average, of 134.8K shares
53.0K
More than atof 3,666 US-listed companies, same days
18%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 46.4%
  • Oct 15, 2026: Short sales 62%
  • Oct 16, 2026: Short sales 48.5%
  • Oct 19, 2026: Short sales 69%
  • Oct 20, 2026: Short sales 45.6%
  • Oct 21, 2026: Short sales 45.4%
  • Oct 22, 2026: Short sales 38.2%
  • Oct 23, 2026: Short sales 42.9%
  • Oct 26, 2026: Short sales 93.6%
  • Oct 27, 2026: Short sales 31.4%
  • Oct 28, 2026: Short sales 42%
  • Oct 29, 2026: Short sales 60.7%
  • Oct 30, 2026: Short sales 59.3%
  • Nov 2, 2026: Short sales 75.7%
  • Nov 3, 2026: Short sales 33.9%
  • Nov 4, 2026: Short sales 45.7%
  • Nov 5, 2026: Short sales 76.1%
  • Nov 6, 2026: Short sales 52.8%
  • Nov 9, 2026: Short sales 49.1%
  • Nov 10, 2026: Short sales 84%
  • Nov 11, 2026: Short sales 46.1%
  • Nov 12, 2026: Short sales 66.7%
  • Nov 13, 2026: Short sales 57.5%
  • Nov 16, 2026: Short sales 65.3%
  • Nov 17, 2026: Short sales 28.9%
  • Nov 18, 2026: Short sales 55.9%
  • Nov 19, 2026: Short sales 48.3%
  • Nov 20, 2026: Short sales 27.8%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

85.16M Insiders' shares264.75% Of the company
  • Broadwood Partners, L.p.TenPercentOwner
    Directly19.54M
  • Broadwood Capital IncTenPercentOwner
    Directly12.11M
  • Neal C BradsherTenPercentOwner
    Directly11.93M
  • Patrick W SmithTenPercentOwner
    Directly1.53M
  • Andrew ArnoDirector
    Directly172.4K
  • Andrea S. JamesChief Financial Officer
    Directly151.2K
  • Andrew J. LastDirector
    Directly58.8K
  • Lou SilvermanDirector
    Directly55.8K
  • Josh RiggsCEO and President
    Directly3,505

A lower bound: it counts only the 9 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.02% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.02%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

3 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

40 Managers, Q2 2026$109M Value of their positions
  • Q3 2025: Managers 28
  • Q4 2025: Managers 35
  • Q1 2026: Managers 41
  • Q2 2026: Managers 40

Institutional investors by quarter

The fund managers holding IMDX, quarter by quarter, from Q2 2023 to Q2 2025, 9 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 40 managers held 18.46M shares, worth $109M. During the quarter 12 opened a position, 13 closed one, 10 added and 7 trimmed.

The largest holders, Q2 2026

  • Broadwood Capital
    In the quarter+6.3%
  • AWM Investment
    In the quarter+1.1%
  • Vanguard Capital Management
    In the quarter+37%
  • Pura Vida Investments
    In the quarter-49%
  • Family Office Research
    In the quarter+190%
  • Geode Capital Management
    In the quarter-2.0%
  • FNY Investment Advisers
    In the quarter-26%
  • Jane Street Group
    In the quarter
  • BlackRock
    In the quarter+11%
  • Vanguard Fiduciary Trust
    In the quarter-6.0%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Insight Molecular Diagnostics's filings show?

Who buys and sells is one part of Insight Molecular Diagnostics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about IMDX's shareholders

Didn't find what you were looking for?

Ask us
Have IMDX's insiders bought or sold?

From Jun 15, 2026 to Nov 20, 2026 Insight Molecular Diagnostics's insiders bought $6.0M and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.

Which well-known managers hold IMDX?

2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $100.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.